Psoriasis Therapy Has Mixed Effects on Cardiovascular Risk Factors

(MedPage Today) -- BOSTON--An evaluation of a common psoriasis drug's effect on one cardiometabolic risk factor instead showed a favorable impact on a different one.
The randomized trial showed that apremilast (Otezla) did not significantly...